Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Nature
|
October 3, 1985
T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4
H Golding, J McCluskey, T I Munitz, et al.
Journal of Virology
|
June 20, 2001
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1
O Scharf, H Golding, L R King, et al.
Blood
|
October 26, 2000
Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection
M Zaitseva, S Lee, C Lapham, et al.
AIDS Research and Human Retroviruses
|
January 1, 1991
Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line
M F Gruber, D S Webb, T L Gerrard, et al.
The Journal of Experimental Medicine
|
March 1, 1988
Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome
H Golding, F A Robey, F T Gates, et al.
Journal of Virology
|
June 1, 1995
Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion
B Golding, J Inman, P Highet, et al.
Cellular Immunology
|
June 1, 1990
CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection
O Shapira-Nahor, H Golding, L K Vujcic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1992
Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway
K Hillman, J Qian, J N Siegel, et al.
Nature Medicine
|
December 13, 1997
Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection
M Zaitseva, A Blauvelt, S Lee, et al.
Microbes and Infection
|
February 28, 2001
Immunity and protection against Brucella abortus
B Golding, D E Scott, O Scharf, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Nature
|
October 3, 1985
T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4
H Golding, J McCluskey, T I Munitz, et al.
Journal of Virology
|
June 20, 2001
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1
O Scharf, H Golding, L R King, et al.
Blood
|
October 26, 2000
Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection
M Zaitseva, S Lee, C Lapham, et al.
AIDS Research and Human Retroviruses
|
January 1, 1991
Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line
M F Gruber, D S Webb, T L Gerrard, et al.
The Journal of Experimental Medicine
|
March 1, 1988
Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome
H Golding, F A Robey, F T Gates, et al.
Journal of Virology
|
June 1, 1995
Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion
B Golding, J Inman, P Highet, et al.
Cellular Immunology
|
June 1, 1990
CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection
O Shapira-Nahor, H Golding, L K Vujcic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1992
Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway
K Hillman, J Qian, J N Siegel, et al.
Nature Medicine
|
December 13, 1997
Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection
M Zaitseva, A Blauvelt, S Lee, et al.
Microbes and Infection
|
February 28, 2001
Immunity and protection against Brucella abortus
B Golding, D E Scott, O Scharf, et al.
Page
of 8